Karuna Therapeutics (Acquired)


Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases. The company focuses on research and development in areas such as oncology, hematology, immunology, and cardiovascular diseases, with a mission to transform patients' lives through science.

Industries

biopharma
health-care
therapeutics

Nr. of Employees

large (251-1000)

Karuna Therapeutics (Acquired)

Boston, Massachusetts, United States, North America


Products

Radiopharmaceutical manufacturing hub

A dedicated manufacturing and supply hub for next‑generation radiopharmaceutical therapies, supporting production and global distribution.

Global R&D hub network (translational research centers)

Distributed R&D centers providing translational research, platform development and cross-site collaboration to accelerate discovery.

Healthcare professional digital portals and patient apps

Digital platforms providing educational materials, clinical guidance and disease‑specific resources for HCPs and patients.


Services

Clinical trial registry and patient‑matching service

Online registry and matching service to help researchers list trials and identify eligible participants.

Medical information and HCP support service

Provision of product information, clinical resources and dedicated contact channels for healthcare professionals.

Pharmacovigilance and safety reporting service

Regional pharmacovigilance operations and adverse event reporting infrastructure.

Grants and medical education funding

Administration of external grant programs and scholarships supporting scientific education and training.

Patient access and financial assistance programs

Resources and programs to help patients understand coverage and access financial support for medicines.

Expertise Areas

  • Clinical trial management
  • Cell and gene therapy development
  • Oncology and immuno-oncology R&D
  • Radiopharmaceutical development and manufacturing
  • Show More (6)

Key Technologies

  • Cell therapy (CAR‑T)
  • Radiopharmaceutical therapy production
  • Biomarker discovery
  • Whole‑genome sequencing
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.